Research Progress in Management of IgA Nephropathy
10.16753/j.cnki.1008-2344.2016.05.024
- VernacularTitle:IgA肾病的治疗进展
- Author:
Yue JIN
1
;
Yuwei WANG
Author Information
1. 皖南医学院弋矶山医院肾内科
- Keywords:
IgA nephropathy;
treatment;
progress
- From:
Journal of Shenyang Medical College
2016;18(5):396-399
- CountryChina
- Language:Chinese
-
Abstract:
Immunoglobulin A nephropathy (IgAN) is the most common type of glomerulonephritis in the world and causes end-stage renal disease (ESRD), So there is a need for effective treatment strategies to prevent the decline in kidney function. Traditional treatment is based on blood pressure control, angiotensin converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB), corticosteroid and immunosuppressive. In recent years, along with a better understangding of its pathogenesis, the new treatment has been put forward.
